home All News open_in_new Full Article
U.S. pharma tariffs spare India’s generic drugmakers — but leave investors jittery
today 2 w. ago attach_file Economics
attach_file
Politics
attach_file
Politics
attach_file
Sport
attach_file
Events
attach_file
Economics
attach_file
Politics
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Economics
attach_file
Politics
attach_file
Politics
attach_file
Economics
attach_file
Politics
2 w. ago
The impact of Trump tariffs on Indian Pharma is limited at best. Here's why | Business News
attach_file
Politics
ID: 4160998785